Promoting good mental health over the menopause transition
- PMID: 38458216
- DOI: 10.1016/S0140-6736(23)02801-5
Promoting good mental health over the menopause transition
Abstract
The potential risk for mental health conditions over the menopause transition shapes women's expectations and informs putative physiological mechanisms regulating women's mental health. We review evidence from prospective studies reporting on associations between mental health conditions and the menopause transition. Major depressive disorder and the more prevalent subthreshold depressive symptoms are the most common conditions studied. We reviewed 12 prospective studies reporting depressive symptoms, major depressive disorder, or both over the menopause transition and found no compelling evidence for a universal increased risk for either condition. However, specific subgroups of participants, primarily defined by menopause-related risk factors (ie, vasomotor symptoms that are severe or disturb sleep, a long duration of the transition, or reproductive hormone dynamics) and psychosocial risk factors (eg, stressful life events), were vulnerable to depressive symptoms. The increased risk of major depressive disorder over the menopause transition appears predominantly in individuals with previous major depressive disorder. Greater focus on recognising risk factors in primary care is warranted. On the basis of scarce data, we found no compelling evidence that risk of anxiety, bipolar disorder, or psychosis is universally elevated over the menopause transition. Potential misattribution of psychological distress and psychiatric disorders to menopause could harm women by delaying accurate diagnosis and the initiation of effective psychotropic treatments, and by creating negative expectations for people approaching menopause. A paradigm shift is needed. We conclude with recommendations for the detection and treatment of depressive symptoms or major depressive disorder and strategies to promote good mental health over the menopause transition, while responsibly preparing and supporting those at risk.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests MSH declares consultation for Rightsteps UK. HJ declares grant funding from the National Institutes of Health (grant numbers U54AG062322 and R01MH128617), Pfizer, and Merck; and consulting for Bayer, Merck, and Hello Therapeutics. MH declares salary funding from the Australian National Health and Medical Research Council, support for meeting attendance from the UK National Institute for Health and Care Excellence, and the following roles: principal investigator for a clinical trial of salpingectomy vs salpingo-oophorectomy for prevention of ovarian cancer (TUBA-WISP II); board member for Breastscreen Victoria; editor for the Cochrane Collaboration; recipient of a fellowship from the Lundbeck Foundation (2022-23); site investigator for a clinical trial of a non-hormonal agent (Q-122) for vasomotor symptoms in patients with breast cancer (QUE Oncology, 2020-22); and site investigator for a clinical trial of a medical device for treating vaginal dryness (Madorra). All other authors declare no competing interests.
Comment in
-
Time for a balanced conversation about menopause.Lancet. 2024 Mar 9;403(10430):877. doi: 10.1016/S0140-6736(24)00462-8. Epub 2024 Mar 5. Lancet. 2024. PMID: 38458210 No abstract available.
-
Reflections on The Lancet menopause Series.Lancet. 2024 Oct 5;404(10460):1306. doi: 10.1016/S0140-6736(24)01710-0. Epub 2024 Sep 25. Lancet. 2024. PMID: 39341214 No abstract available.
Similar articles
-
Depressive disorders and the menopause transition.Maturitas. 2012 Feb;71(2):120-30. doi: 10.1016/j.maturitas.2011.11.017. Epub 2011 Dec 21. Maturitas. 2012. PMID: 22196311 Review.
-
Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN).Psychol Med. 2011 Sep;41(9):1879-88. doi: 10.1017/S003329171100016X. Epub 2011 Feb 9. Psychol Med. 2011. PMID: 21306662 Free PMC article.
-
Evaluation and management of depressive and anxiety symptoms in midlife.Climacteric. 2012 Feb;15(1):3-9. doi: 10.3109/13697137.2011.620188. Epub 2011 Dec 1. Climacteric. 2012. PMID: 22132727 Review.
-
Does family history of depression predict major depression in midlife women? Study of Women's Health Across the Nation Mental Health Study (SWAN MHS).Arch Womens Ment Health. 2014 Aug;17(4):269-78. doi: 10.1007/s00737-014-0433-8. Epub 2014 Jun 21. Arch Womens Ment Health. 2014. PMID: 24952069 Free PMC article.
-
The impact of extroversion or menopause status on depressive symptoms among climacteric women in Taiwan: neuroticism as moderator or mediator?Menopause. 2008 Jan-Feb;15(1):138-43. doi: 10.1097/gme.0b013e31804b419d. Menopause. 2008. PMID: 17545919
Cited by
-
Pelvic floor symptom progression increases risk for depression, while better physical performance is protective in Asian midlife women.Sci Rep. 2025 May 24;15(1):18069. doi: 10.1038/s41598-025-02805-2. Sci Rep. 2025. PMID: 40413257 Free PMC article.
-
Depression symptoms in perimenopausal women with somatic pain: nomogram construction based on a logistic regression model.Front Public Health. 2025 May 9;13:1528718. doi: 10.3389/fpubh.2025.1528718. eCollection 2025. Front Public Health. 2025. PMID: 40416662 Free PMC article.
-
Sex differences in onset and prevalence of 108 diseases and multimorbidity across lifespan in Yichang, China: quantitative analysis of real-world linked electronic health records.BMJ Open. 2025 Jul 15;15(7):e101439. doi: 10.1136/bmjopen-2025-101439. BMJ Open. 2025. PMID: 40664420 Free PMC article.
-
HDC downregulation induced by chronic stress promotes ovarian cancer progression via the IL-6/STAT3/S100A9 pathway.Front Pharmacol. 2024 Dec 10;15:1485885. doi: 10.3389/fphar.2024.1485885. eCollection 2024. Front Pharmacol. 2024. PMID: 39720595 Free PMC article.
-
Effects of different types of badminton training on sleep quality, anxiety, and related baseline physiological markers in graduate students with sleep disorders: a randomized controlled trial.BMC Public Health. 2025 Apr 14;25(1):1390. doi: 10.1186/s12889-025-22551-4. BMC Public Health. 2025. PMID: 40229718 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical